查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1584741

抗生素市場：按作用機制、藥物類別、頻譜、類別、應用、給藥途徑、分銷管道 - 2025-2030 年全球預測

Antibiotics Market by Action Mechanism, Drug Class, Spectrum, Category, Application, Route of Administration, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年抗生素市值為430.8億美元，預計2024年將達到457.4億美元，複合年成長率為6.81%，到2030年將達到683.5億美元。

抗生素市場涉及尋找透過殺死細菌或抑制細菌生長來對抗細菌感染的藥物。此系列包括各種類別，如 BETA-內醯胺類、四環黴素、大環內酯類、Aminoglycosides等，涵蓋人類健康、獸醫用途和農業用途。對抗生素的需求源於它們在治療細菌性疾病、預防感染疾病傳播和保護公眾健康方面的重要作用，這使得它們在手術、癌症治療和流行病期間作為預防藥物尤其重要。最終用途範圍從醫院、診所、家庭保健到畜牧業，抗生素可提高生產力並保護牲畜的健康。細菌感染的增加、醫療保健改善導致新興市場的需求增加以及對抗抗藥性菌株的抗生素配方創新推動了成長。潛在的機會在於開發窄頻譜、利用生物技術開發新型抗菌藥物以及投資快速診斷技術以更精確地調整抗生素的使用。然而，抗生素抗藥性、監管障礙和抗生素生產盈利下降等挑戰正在阻礙市場擴張。也有一些局限性，例如抗生素的過度使用和濫用可能導致多重抗藥性細菌的出現，以及關於在家畜中使用抗生素的爭論可能導致抗藥性細菌的出現。在創新方面，重點研究胜肽、探索與免疫療法的協同效應以及人工智慧驅動的藥物發現有助於推動產業成長。技術創新的潛在領域包括開發突破抗藥性的分子和次世代定序技術，以提高抗生素部署的準確性，這表明市場有能力實現技術主導的轉型。儘管抗生素市場面臨許多挑戰，但對創新和監管合作的策略重點可以為這個重要醫療保健產業的持續成長和市場開拓鋪平道路。

主要市場統計
基準年[2023] 430.8億美元
預測年份 [2024] 457.4億美元
預測年份 [2030] 683.5億美元
複合年成長率（%） 6.81%

市場動態：揭示快速發展的抗生素市場的關鍵市場洞察

供需的動態交互作用正在改變抗生素市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球感染疾病和慢性病盛行率不斷上升
    • 傾向於疾病的早期診斷和治療
    • 新抗生素測試開發的臨床試驗數量增加
  • 市場限制因素
    • 對抗生素抗藥性的擔憂
  • 市場機會
    • 治療抗生素抗藥性微生物感染疾病的先進前景分子和新型聯合治療
    • 加大開發新藥研發投入
  • 市場挑戰
    • 使用抗生素的副作用

波特五力：駕馭抗生素市場的策略工具

波特的「五力」框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解抗生素市場的外部影響

外部宏觀環境因素對抗生素市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解抗生素市場的競爭狀況

抗生素市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣抗生素市場供應商績效評估

FPNV定位矩陣是評估抗生素市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製抗生素市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，抗生素市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地感染疾病和慢性病的盛行率正在增加。
      • 疾病的早​​期診斷和治療趨勢
      • 新藥開發的臨床試驗數量增加抗生素

測試

    • 抑制因素
      • 與抗生素抗藥性相關的擔憂
    • 機會
      • 先進的有潛力的分子和新的聯合治療可治療抗生素抗藥性微生物感染疾病
      • 加大開發新藥的研發投入
    • 任務
      • 使用抗生素的副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 抗生素市場行動機制

  • 細胞壁合成抑制劑
  • DNA合成抑制劑
  • 黴菌酸抑制劑
  • 蛋白質合成抑制劑
  • RNA合成抑制劑

第7章依藥物類別分類的抗生素市場

  • Aminoglycosides
  • 碳青黴烯類
  • 頭孢菌素
  • Fluoroquinolones
  • 大環內酯
  • 青黴素
  • 磺胺類藥物

第8章抗生素市場頻譜

  • 抗生素種類廣泛
  • 窄效抗生素

第9章抗生素市場：依類別

  • 品牌抗生素
  • 常見抗生素

第10章抗生素市場：依應用分類

  • 耳部感染疾病
  • 胃腸道感染疾病
  • 呼吸道感染疾病
  • 敗血症
  • 皮膚感染疾病
  • 尿道感染

第11章抗生素市場：依給藥途徑

  • 口服
  • 胃腸外的

第12章抗生素市場：按分銷管道

  • 離線
  • 線上

第13章美洲抗生素市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第14章亞太地區抗生素市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第15章歐洲、中東和非洲抗生素市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第16章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Amneal Pharmaceuticals LLC
  • Astellas Pharma, Inc.
  • Bausch Health Companies, Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Cadila Healthcare Ltd.
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Glenmark Pharmaceuticals Limited
  • Hetero Healthcare
  • Johnson & Johnson Services, Inc.
  • KYORIN Holdings, Inc.
  • Lupin Limited
  • Melinta Therapeutics, Inc.
  • Merck & Co., Inc.
  • MerLion Pharmaceuticals GmbH
  • Mylan NV by Viatris
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Shionogi & Co., Ltd.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-434CCDA0512F

The Antibiotics Market was valued at USD 43.08 billion in 2023, expected to reach USD 45.74 billion in 2024, and is projected to grow at a CAGR of 6.81%, to USD 68.35 billion by 2030.

The antibiotics market encompasses the investigation of drugs that combat bacterial infections by either killing bacteria or hindering their growth. Its scope includes various classes such as beta-lactams, tetracyclines, macrolides, aminoglycosides, and others, spanning applications in human health, veterinary use, and agricultural purposes. The necessity for antibiotics arises from their crucial role in treating bacterial diseases, preventing the spread of infections, and safeguarding public health, notably essential in surgeries, cancer treatment, and as prophylaxis during pandemics. End-use scopes range widely from hospitals, clinics, and home healthcare settings to animal husbandry, where antibiotics enhance productivity and safeguard livestock health. Growth is propelled by increasing bacterial infections, rising demand in emerging markets due to improved healthcare, and innovations in antibiotic formulations combating resistant strains. Potential opportunities lie in the development of narrow-spectrum antibiotics, leveraging biotechnology for novel antimicrobial agents, and investing in rapid diagnostic technologies that tailor antibiotic use more precisely. However, challenges such as antibiotic resistance, regulatory hurdles, and the decline in antibiotic production profitability impede market expansion. Limitations include the overuse and misuse of antibiotics, leading to the emergence of multi-drug-resistant organisms, and debates surrounding the use of antibiotics in livestock contributing to resistance. For innovation, focus on research in antimicrobial peptides, exploring synergies with immunotherapy, and leveraging AI for drug discovery can steer industry growth. Viable areas for innovation include developing resistance-breaking molecules and next-generation sequencing technology to improve precision in antibiotic deployment, suggesting a market poised for technologically driven transformation. Thus, while the antibiotics market encounters numerous challenges, strategic focus on innovation and regulatory collaboration can open pathways for sustainable growth and development in this critical healthcare sector.

KEY MARKET STATISTICS
Base Year [2023] USD 43.08 billion
Estimated Year [2024] USD 45.74 billion
Forecast Year [2030] USD 68.35 billion
CAGR (%) 6.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antibiotics Market

The Antibiotics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious and chronic diseases worldwide
    • Inclination toward early diagnosis and treatment of diseases
    • Rise in the number of clinical trials for the development of novel antibiotics trials
  • Market Restraints
    • Concerns associated with antibiotics resistance
  • Market Opportunities
    • Advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections
    • Growing in R&D and investments for the development of new drugs
  • Market Challenges
    • Side effects caused by the usage of antibiotic drugs

Porter's Five Forces: A Strategic Tool for Navigating the Antibiotics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antibiotics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antibiotics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antibiotics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antibiotics Market

A detailed market share analysis in the Antibiotics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antibiotics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antibiotics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antibiotics Market

A strategic analysis of the Antibiotics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antibiotics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amneal Pharmaceuticals LLC, Astellas Pharma, Inc., Bausch Health Companies, Inc., Bayer AG, Bristol-Myers Squibb Company, Cadila Healthcare Ltd., Dr. Reddy's Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche AG, Glenmark Pharmaceuticals Limited, Hetero Healthcare, Johnson & Johnson Services, Inc., KYORIN Holdings, Inc., Lupin Limited, Melinta Therapeutics, Inc., Merck & Co., Inc., MerLion Pharmaceuticals GmbH, Mylan N.V. by Viatris, Novartis International AG, Pfizer Inc., Sanofi S.A., Shionogi & Co., Ltd., Sun Pharmaceutical Industries Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Antibiotics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Action Mechanism, market is studied across Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors.
  • Based on Drug Class, market is studied across Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, Macrolides, Penicillin, and Sulfonamides.
  • Based on Spectrum, market is studied across Broad-spectrum Antibiotics and Narrow-spectrum Antibiotics.
  • Based on Category, market is studied across Branded Antibiotics and Generic Antibiotics.
  • Based on Application, market is studied across Ear Infection, Gastrointestinal Infections, Respiratory Infections, Septicemia, Skin Infections, and Urinary Tract Infections.
  • Based on Route of Administration, market is studied across Oral and Parenteral.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Inclination toward early diagnosis and treatment of diseases
      • 5.1.1.3. Rise in the number of clinical trials for the development of novel antibiotics

trials

    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with antibiotics resistance
    • 5.1.3. Opportunities
      • 5.1.3.1. Advanced prospect molecules and novel combination therapies to treat antibiotic-resistant microbial infections
      • 5.1.3.2. Growing in R&D and investments for the development of new drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects caused by the usage of antibiotic drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antibiotics Market, by Action Mechanism

  • 6.1. Introduction
  • 6.2. Cell Wall Synthesis Inhibitors
  • 6.3. DNA Synthesis Inhibitors
  • 6.4. Mycolic Acid Inhibitors
  • 6.5. Protein Synthesis Inhibitors
  • 6.6. RNA Synthesis Inhibitors

7. Antibiotics Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Aminoglycosides
  • 7.3. Carbapenem
  • 7.4. Cephalosporin
  • 7.5. Fluoroquinolone
  • 7.6. Macrolides
  • 7.7. Penicillin
  • 7.8. Sulfonamides

8. Antibiotics Market, by Spectrum

  • 8.1. Introduction
  • 8.2. Broad-spectrum Antibiotics
  • 8.3. Narrow-spectrum Antibiotics

9. Antibiotics Market, by Category

  • 9.1. Introduction
  • 9.2. Branded Antibiotics
  • 9.3. Generic Antibiotics

10. Antibiotics Market, by Application

  • 10.1. Introduction
  • 10.2. Ear Infection
  • 10.3. Gastrointestinal Infections
  • 10.4. Respiratory Infections
  • 10.5. Septicemia
  • 10.6. Skin Infections
  • 10.7. Urinary Tract Infections

11. Antibiotics Market, by Route of Administration

  • 11.1. Introduction
  • 11.2. Oral
  • 11.3. Parenteral

12. Antibiotics Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Offline
  • 12.3. Online

13. Americas Antibiotics Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Antibiotics Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Antibiotics Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Amneal Pharmaceuticals LLC
  • 3. Astellas Pharma, Inc.
  • 4. Bausch Health Companies, Inc.
  • 5. Bayer AG
  • 6. Bristol-Myers Squibb Company
  • 7. Cadila Healthcare Ltd.
  • 8. Dr. Reddy's Laboratories
  • 9. Eli Lilly and Company
  • 10. F. Hoffmann-La Roche AG
  • 11. Glenmark Pharmaceuticals Limited
  • 12. Hetero Healthcare
  • 13. Johnson & Johnson Services, Inc.
  • 14. KYORIN Holdings, Inc.
  • 15. Lupin Limited
  • 16. Melinta Therapeutics, Inc.
  • 17. Merck & Co., Inc.
  • 18. MerLion Pharmaceuticals GmbH
  • 19. Mylan N.V. by Viatris
  • 20. Novartis International AG
  • 21. Pfizer Inc.
  • 22. Sanofi S.A.
  • 23. Shionogi & Co., Ltd.
  • 24. Sun Pharmaceutical Industries Limited
  • 25. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. ANTIBIOTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIBIOTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIBIOTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANTIBIOTICS MARKET SIZE, BY BRANDED ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ANTIBIOTICS MARKET SIZE, BY GENERIC ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ANTIBIOTICS MARKET SIZE, BY EAR INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANTIBIOTICS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ANTIBIOTICS MARKET SIZE, BY SEPTICEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ANTIBIOTICS MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL ANTIBIOTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL ANTIBIOTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL ANTIBIOTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 331. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 332. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2023